1-9 of 9
John Welch
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Adverse Outcomes in Acute Myeloid Leukemia Are Associated with Tumor Cell-Mediated Immunosuppression

Francesca Ferraro, Christopher A Miller, Keegan A Christensen, Nichole M Helton, Michelle O'Laughlin, Robert Fulton, Jessica Kohlschmidt, Ann-Kathrin Eisfeld, Bloomfield Clara, Sai Mukund Ramakrishnan, Lukas D Wartman, John Welch, Matthew Christopher, Sharon E Heath, Peter Westervelt, Jack D Baty, Jacqueline E. Payton, Michael Retting, Daniel C. Link, Matthew J. Walter, John F. DiPersio, Ryan Day, Geoffrey L. Uy, Matthew Schuelke, David H Spencer, Timothy J Ley
Journal: Blood
Blood (2021) 138 (Supplement 1): 800.
https://doi.org/10.1182/blood-2021-148645
Published: 2021
Journal Articles

Ten-Day Decitabine with Venetoclax (DEC10-VEN) in Acute Myeloid Leukemia and Myelodysplastic Syndrome: Updated Results of a Phase II Trial

Abhishek Maiti, Courtney D. DiNardo, Caitlin R. Rausch, Naveen Pemmaraju, Guillermo Garcia-Manero, Maro Ohanian, Naval Daver, Ghayas C. Issa, Gautam Borthakur, Farhad Ravandi, Yesid Alvarado, Tapan M. Kadia, Nicholas J. Short, Elias J. Jabbour, Guillermo Montalban-Bravo, Nitin Jain, Steven M. Kornblau, Lucia Masarova, William G. Wierda, Koji Sasaki, Koichi Takahashi, Musa Yilmaz, Jan A. Burger, Zeev E. Estrov, Srdan Verstovsek, Michael Andreeff, Prithviraj Bose, Alessandra Ferrajoli, Philip A. Thompson, Kathryn Montalbano, Kenneth Vaughan, Carol A. Bivins, Sherry A. Pierce, Wei Qiao, Jing Ning, John Welch, Hagop Kantarjian, Marina Konopleva
Journal: Blood
Blood (2021) 138 (Supplement 1): 1270.
https://doi.org/10.1182/blood-2021-153530
Published: 2021
Journal Articles

Molecular Profiling of Decitabine Response in MDS and AML Patients

Pawan Kumar Upadhyay, PhD, Jeremy Beales, MS, Nakul Kumar Shah, MD, Christopher A Miller, PhD, Allegra A Petti, PhD, Daniel C. Link, MD, Timothy J Ley, MD, John Welch, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 40.
https://doi.org/10.1182/blood-2020-141292
Published: 2020
Journal Articles

Identification of AML/MDS Drug Sensitization By In Vivo Chemotherapy Administration

John Welch, MDPhD, Lakshmi R Chelapareddy, MD, Michelle Richardson, Ryo Kita, MDPhD, Megan Haney, Susanna Wen, PhD, Hiroomi Tada, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 32–33.
https://doi.org/10.1182/blood-2020-142165
Published: 2020
Journal Articles

Genomic analysis of germ line and somatic variants in familial myelodysplasia/acute myeloid leukemia

Clinical Trials & Observations
Jane E. Churpek, Khateriaa Pyrtel, Krishna-Latha Kanchi, Jin Shao, Daniel Koboldt, Christopher A. Miller, Dong Shen, Robert Fulton, Michelle O’Laughlin, Catrina Fronick, Iskra Pusic, Geoffrey L. Uy, Evan M. Braunstein, Mark Levis, Julie Ross, Kevin Elliott, Sharon Heath, Allan Jiang, Peter Westervelt, John F. DiPersio, Daniel C. Link, Matthew J. Walter, John Welch, Richard Wilson, Timothy J. Ley, Lucy A. Godley, Timothy A. Graubert
Journal: Blood
Blood (2015) 126 (22): 2484–2490.
https://doi.org/10.1182/blood-2015-04-641100
Published: 2015
Includes: Supplemental data
Journal Articles

Natural Ligands for Rxra, but Not Rara, Are Observed in Mouse Bone Marrow Cells, and Are Augmented in Response to 5FU and GCSF

Haixa Niu, PhD, John Welch, MDPhD
Journal: Blood
Blood (2014) 124 (21): 4339.
https://doi.org/10.1182/blood.V124.21.4339.4339
Published: 2014
Journal Articles

A Phase I Dose Escalation Study Of Oral Bexarotene In Combination With Intravenous Decitabine In Patients With AML

John Welch, MD/PhD, Haixa Niu, PhD, Geoffrey L. Uy, MD, Peter Westervelt, MD, PhD, Camille N. Abboud, MD, Ravi Vij, MD, Keith E. Stockerl-Goldstein, MD, Meagan Jacoby, MD, Iskra Pusic, MD, Mark A. Schroeder, MD, John F. Dipersio, MD, PhD, Amanda F Cashen, MD
Journal: Blood
Blood (2013) 122 (21): 3931.
https://doi.org/10.1182/blood.V122.21.3931.3931
Published: 2013
Journal Articles

Plerixafor, G-CSF and Azacitidine For The Treatment Of MDS: Results Of a Phase I Trial

Mark A. Schroeder, MD, Marcus Grillot, Teresa Reineck, Meagan A Jacoby, MD/PhD, Rizwan Romee, MD, Iskra Pusic, MD, John Welch, MD/PhD, Geoffrey L. Uy, MD, Amanda F Cashen, MD, Keith E. Stockerl-Goldstein, MD, Ravi Vij, MD, Shashikant Kulkarni, PhD, Peter Westervelt, MD, PhD, Matthew J. Walter, MD, John F. Dipersio, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2816.
https://doi.org/10.1182/blood.V122.21.2816.2816
Published: 2013
Journal Articles

The Role Of Early TP53 Mutations On The Evolution Of Therapy-Related AML

Terrence Neal Wong, MD PhD, Giridharan Ramsingh, M.D, Andrew Young, Dong Shen, Chris Miller, PhD, Tamara Lamprecht, B.S., Sharon Heath, Robert S. Fulton, Elaine R. Mardis, PhD, Li Ding, Peter Westervelt, MD, PhD, John Welch, PhD/MD, Matthew J. Walter, MD, Timothy Graubert, MD, John F. DiPersio, MD, PhD, Timothy J. Ley, MD, Todd E Druley, MD, PhD, Richard K Wilson, PhD, Daniel C. Link, MD
Journal: Blood
Blood (2013) 122 (21): 5.
https://doi.org/10.1182/blood.V122.21.5.5
Published: 2013